Současnost klinických studií očkovacích látek v České republice
[Current situation in clinical trials with vaccines in the Czech Republic]
Jazyk čeština Země Česko Médium print
Typ dokumentu časopisecké články
PubMed
25523220
PII: 50671
- MeSH
- biomedicínský výzkum normy trendy MeSH
- etické komise MeSH
- klinické zkoušky jako téma metody normy trendy MeSH
- lidé MeSH
- testované léky aplikace a dávkování MeSH
- vakcíny aplikace a dávkování MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Česká republika MeSH
- Názvy látek
- testované léky MeSH
- vakcíny MeSH
Clinical trials are an important part of clinical research. The conduction of clinical trials is strictly regulated and has to comply with an approved protocol. Local regulatory authorities, independent ethic committees, sponsors of clinical trials as well as the investigators are involved from the submission until the very end of the trial. All clinical trials performed in the Czech Republic have to be approved by the State Institute for Drug Control and by the Ethics Committee. The regulatory bodies and independent ethics committees evaluate and continuously supervise the justification and protocol of the clinical trial, quality of the investigational medicinal products and, primarily, the safety of the participants (patients and/or healthy volunteers) in clinical trials. In the Czech Republic there are many advanced clinical research centres, either located in private practices or within hospitals. The investigators are able to conduct a wide variety of clinical trials and recruit a high number of subjects for the trials, as well as to comply with the Good Clinical Practice guidelines and other regulatory requirements. The aim of this article is to summarise the current situation of clinical trials in the Czech Republic as well as the opportunities for getting involved in clinical trials and obligations arising for health professionals from such an involvement.